Is ARRAYIT CORPORATION (OTCMKTS:ARYC) a Buy? The Stock Reported Less Sellers

May 16, 2018 - By Vivian Park

The stock of ARRAYIT CORPORATION (OTCMKTS:ARYC) registered a decrease of 73.33% in short interest. ARYC’s total short interest was 2,000 shares in May as published by FINRA. Its down 73.33% from 7,500 shares, reported previously.

The stock increased 6.67% or $0.001 during the last trading session, reaching $0.016. About 1.11 million shares traded. Arrayit Corporation (OTCMKTS:ARYC) has 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.

Arrayit Corporation, a life sciences technology company, develops, makes, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company has market cap of $12.70 million. The firm is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It currently has negative earnings. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: